These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 181839)

  • 21. Neutral proteases of human granulocytes. III. Interaction between human granulocyte elastase and plasma protease inhibitors.
    Ohlsson K; Olsson I
    Scand J Clin Lab Invest; 1974 Dec; 34(4):349-55. PubMed ID: 4142517
    [No Abstract]   [Full Text] [Related]  

  • 22. Kinetic studies on the fragmentation of the third component of complement (C3) by trypsin.
    Minta JO; Man D; Movat HZ
    J Immunol; 1977 Jun; 118(6):2192-8. PubMed ID: 864257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoreactive granulocyte elastase in human serum.
    Ohlsson K; Olsson AS
    Hoppe Seylers Z Physiol Chem; 1978 Nov; 359(11):1531-9. PubMed ID: 730111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cleavage of C3 by neutral proteases from granulocytes in pleural empyema.
    Suter S; Nydegger UE; Roux L; Waldvogel FA
    J Infect Dis; 1981 Dec; 144(6):499-508. PubMed ID: 6460066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
    Geiger H; Good RA; Day NK
    Clin Nephrol; 1975; 3(4):139-47. PubMed ID: 1149337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cleavage of the fifth component of complement and generation of a functionally active C5b6-like complex by human leukocyte elastase.
    Vogt W
    Immunobiology; 2000 Jan; 201(3-4):470-7. PubMed ID: 10776801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells.
    Orr FW; Varani J; Kreutzer DL; Senior RM; Ward PA
    Am J Pathol; 1979 Jan; 94(1):75-83. PubMed ID: 569981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C3, C5 components and C3a, C4a, and C5a fragments of the complement system.
    Janatova J
    Methods Enzymol; 1988; 162():579-625. PubMed ID: 3265757
    [No Abstract]   [Full Text] [Related]  

  • 29. Elastase of Pseudomonas aeruginosa: inactivation of complement components and complement-derived chemotactic and phagocytic factors.
    Schultz DR; Miller KD
    Infect Immun; 1974 Jul; 10(1):128-35. PubMed ID: 4210424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Granulocyte proteases in human maxillary sinus secretions.
    Engquist S; Lundberg C; Venge P
    Scand J Infect Dis; 1983; 15(1):119-23. PubMed ID: 6302829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of anaphylatoxins through proteolytic processing of C3 and C5 by house dust mite protease.
    Maruo K; Akaike T; Ono T; Okamoto T; Maeda H
    J Allergy Clin Immunol; 1997 Aug; 100(2):253-60. PubMed ID: 9275149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3.
    Hong YQ; Ghebrehiwet B
    Clin Immunol Immunopathol; 1992 Feb; 62(2):133-8. PubMed ID: 1730152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cleavage of membrane bound C3bi, an intermediate of the third component of complement, to C3c and C3d-like fragments by crude leucocyte lysosomal lysates and purified leucocyte elastase.
    Carlo JR; Spitznagel JK; Studer EJ; Conrad DH; Ruddy S
    Immunology; 1981 Oct; 44(2):381-91. PubMed ID: 7028603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum complement components in patients with trachoma.
    Sen DK; Sarin GS; Hiranandani M; Baveja UK
    Br J Ophthalmol; 1985 Sep; 69(9):707-10. PubMed ID: 3876110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative inefficiency of terminal complement activation.
    Bhakdi S; Fassbender W; Hugo F; Carreno MP; Berstecher C; Malasit P; Kazatchkine MD
    J Immunol; 1988 Nov; 141(9):3117-22. PubMed ID: 3262681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement factors in gingival crevice material from healthy and inflamed gingiva in humans.
    Attström R; Laurel AB; Lahsson U; Sjöholm A
    J Periodontal Res; 1975 Feb; 10(1):19-27. PubMed ID: 124331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A molecular concept of the properdin pathway.
    Medicus RG; Schreiber RD; Götze O; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1976 Feb; 73(2):612-6. PubMed ID: 54923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Degradation of human immunoglobulins G and M and complement factors C3 and C5 by black-pigmented Bacteroides.
    Sundqvist G; Carlsson J; Herrmann B; Tärnvik A
    J Med Microbiol; 1985 Feb; 19(1):85-94. PubMed ID: 3968707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement bridges between cells analysis of a possible cell-cell interaction mechanism.
    Dierich MP; Landen B
    J Exp Med; 1977 Dec; 146(6):1484-99. PubMed ID: 925610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.